Restored autophagy is protective against PAK3-induced cardiac dysfunction

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Cellular Signaling

Background:

• Heart failure remains a major global health challenge with limited effective treatments.
• P21-activated kinase 3 (PAK3) has been identified as upregulated in failing hearts.
• The precise role of PAK3 in cardiac pathophysiology is not fully understood.

Purpose of the Study:

• To investigate the role of PAK3 in the progression of heart failure.
• To elucidate the molecular mechanisms by which PAK3 affects cardiac function.
• To explore the therapeutic potential of targeting the PAK3-autophagy axis in heart failure.

Main Methods:

• Cardiac-specific PAK3 overexpression in mouse models.
• Assessment of cardiac function and pathological remodeling.
• Investigation of autophagy regulation in cardiomyocytes and human samples.
• Pharmacological intervention with an autophagic inducer.

Main Results:

• Cardiac-specific PAK3 overexpression led to exacerbated cardiac dysfunction, hypertrophy, fibrosis, and apoptosis.
• PAK3 was found to suppress autophagy by hyper-activating mTORC1.
• Inhibition of PAK3-mediated autophagy suppression improved cardiac function in vivo.
• Targeting the PAK3-autophagy pathway demonstrated therapeutic efficacy.

Conclusions:

• PAK3 plays a critical role in promoting heart failure progression by inhibiting myocardial autophagy.
• PAK3 acts as a negative regulator of autophagy via mTORC1 signaling.
• Modulating the PAK3-autophagy axis represents a promising therapeutic strategy for heart failure.